Capacity Building

Clinical Trials BC attracts new investment from networks, associations and industry partners by promoting the province’s clinical trials capacity, technology platforms and expertise worldwide. We facilitate connections and partnerships with our diverse group of stakeholders.

BC Clinical Research Showcase


The BC Clinical Research Showcase (BC Showcase) is a website created by Clinical Trials BC to highlight the development and achievements of British Columbia’s clinical research community. BC Showcase is used as a global marketing tool, featuring the experienced investigators, research institutes, infrastructure and resources that collectively make the province a premier location for clinical trials.

The BC Showcase is hosted on the Canadian Clinical Trials Asset Map (CCTAM). This site is a searchable web-based database designed to communicate Canada’s clinical research strengths to all stakeholders, including clinical trial sponsors.

We’re working to expand the BC Showcase’s listings. If you’d like more information, or if you want your research team profiled, please contact Alison Orth.

Clinical Trials Management System

As part of the Canadian Institutes of Health Research (CIHR) business plan submission, the BC SUPPORT Unit, a fellow operational unit in the BC Academic Health Science Network, committed to providing BC researchers with access to a Clinical Trials Management System (CTMS). A CTMS enables management of many aspects of clinical trials including: study start-up timelines, tracking and reporting of protocol information and accrual data, study financial management and billing compliance.


Clinical Trials BC builds relationships with many national and international partners, including peer provincial organizations, international regulatory bodies and industry. Our global profile and access enables us to identify clinical research opportunities for BC sites and to coordinate investment inquiries and potential new relationships between partners.


Clinical Trials BC has entered into a Memorandum of Understanding (MoU) with LifeSciences BC to collaborate on a range of initiatives, including efforts to increase awareness for trials and investment by private industry, tracking Key Performance Indicators, measuring economic impact of clinical research in BC, and advocating on areas of mutual interest.